Zim Laboratories Ltd.

Financial

	Zim Laboratories	Venus Remedies	Lyka Labs
Operational Metrics
Pharmaceutical Sector
R&D as a % of Total Sales	9.7 %	n/a	n/a
Financials
5 yr Average ROE	6.88 %	6.64 %	145.3 %
5yr average Equity Multiplier	1.92	1.46	-0.06
5yr Average Asset Turnover Ratio	0.96	0.89	0.64
5yr Avg Net Profit Margin	3.75 %	4.93 %	-21.64 %
Price to Book	1.83	0.9	4.19
P/E	28.92	12.84	100.65
5yr Avg Cash Conversion Cycle	35.7 Days	72.13 Days	16.94 Days
Inventory Days	67.21 Days	93.66 Days	26.54 Days
Days Receivable	97.06 Days	47.69 Days	77.33 Days
Days Payable	149.76 Days	52.51 Days	133.6 Days
5yr Average Interest Coverage Ratio	3.65	176.34	0.6
5yr Avg ROCE	13.04 %	6.96 %	22.35 %
5yr Avg Operating Profit Margin	11.53 %	10.58 %	20.24 %
5 yr average Debt to Equity	0.42	0.22	-0.79
5yr CAGR Net Profit	39.21 %	n/a	-47.18 %
5yr Average Return on Assets	3.71 %	5.11 %	-5.63 %
Shareholdings
Promoter Holding	33.26 %	41.76 %	58.16 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.95 %	10.37 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	-0.72 %

Business

	Zim Laboratories	Venus Remedies	Lyka Labs
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Pharmaceuticals 0 Formulations 0 Bulk Drugs 0	Product Wise Break-Up Bulk Drugs 0 Pharmaceutical 0 Pharmaceuticals 100.0 Formulations 0	Product Wise Break-Up Bulk Drugs 3.2 Pharmaceutical 0 Pharmaceuticals 0 Formulations 96.8
Location Wise Break-Up	Location Wise Break-Up Asia (Ex India) 34.0 Middle East 27.0 India 22.0 Africa 12.0 International 0 Domestic 0 Others 5.0	Location Wise Break-Up Domestic 0 Middle East 0 India 33.0 Africa 0 Asia (Ex India) 0 International 0 Others 67.0	Location Wise Break-Up India 60.09 Middle East 0 India 0 Africa 0 Asia (Ex India) 0 International 39.91
Capex	Capex India 89.12 Others 10.88	-	-
Customer Segment	Customer Segment Export 82.0 Government 16.0 Deemed Export 2.0	-	-
Asset Break-Up	Asset Break-Up India 91.68 Others 8.32	-	-